Contact this trialFirst, we need to learn more about you.
LHRH Agonist
ADT + Abiraterone Acetate + Prednisone + Apalutamide for Prostate Cancer
Recruiting2 awardsPhase 3
Kelowna, British Columbia
This trial is for prostate cancer patients who have received radiation and hormonal therapy, whose PSA is still detectable, and have received 6-12 months of hormonal therapy. The study drugs are LHRHA, Abiraterone Acetate, Apalutamide, and Prednisone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service